Palabras claves: Adverse events, albendazole, Brugia malayi, DEC, Diethylcarbamazine, Drug regimens for LF, drug safety, Ivermectin, Lymphatic filariasis, Programme to Eliminate Lymphatic Filariasis (PELF), Tropical disease control, Wuchereria bancrofti
Autores: Addiss D.G., Awadzi K., Beach M.J., Belizario V.Y., Dunyo S.K., Gyapong J.O., Horton J., Hossain M., Ismail M.M., Jayakody R.L., Lammie P.J., Lazdins J.K., Makunde W., Mauricio Espinel, Ottesen E.A., Richard-Lenoble D., Selve B., Shenoy R.K., Simonsen P.E., Wamae C.N., Weerasooriya M.V., Witt C.
